We are live on
!
Find out more
RCM
Radnor Capital Management Portfolio holdings
AUM
$712M
1-Year Est. Return
34.39%
This Fund
S&P 500
This Quarter
Est. Return
-3.47%
1 Year Est. Return
+34.39%
3 Year Est. Return
+86.61%
5 Year Est. Return
+116%
10 Year Est. Return
–
AUM
$294M
AUM Growth
-$18.5M
(-5.9%)
Cap. Flow
-$5.27M
Cap. Flow
% of AUM
-1.79%
Top 10 Holdings %
Top 10 Hldgs %
40.95%
Holding
188
New
7
Increased
10
Reduced
89
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutrien
NTR
|
+$604K |
| 2 |
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
|
+$564K |
| 3 |
Protolabs
PRLB
|
+$429K |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$403K |
| 5 |
MDP
Meredith Corporation
MDP
|
+$320K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$1.74M |
| 2 |
POT
Potash Corp Of Saskatchewan
POT
|
+$648K |
| 3 |
WAGE
WageWorks, Inc.
WAGE
|
+$520K |
| 4 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$487K |
| 5 |
BKS
Barnes & Noble
BKS
|
+$299K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.5% |
| 2 | Industrials | 17.74% |
| 3 | Technology | 13.97% |
| 4 | Energy | 10.08% |
| 5 | Financials | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Viridian Therapeutics
VRDN
$2.67B
| $70K | 0.02% |
667
| – | – |
|
|
GNC
177
DELISTED
GNC Holdings, Inc.
GNC
| $39K | 0.01% |
+10,000
| New | +$41.6K |
|
178
Ametek
AME
$58.2B
| – | – |
-3,141
| Closed | -$228K |
|
|
BNY
179
Bank of New York Mellon
BNY
$107B
| – | – |
-3,792
| Closed | -$204K |
|
180
Quest Diagnostics
DGX
$26.3B
| – | – |
-2,073
| Closed | -$204K |
|
181
General Mills
GIS
$19.7B
| – | – |
-4,654
| Closed | -$276K |
|
182
Southern Company
SO
$107B
| – | – |
-4,165
| Closed | -$200K |
|
|
WBA
183
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-2,800
| Closed | -$203K |
|
|
PDCO
184
DELISTED
Patterson Companies, Inc.
PDCO
| – | – |
-13,490
| Closed | -$487K |
|
|
WAGE
185
DELISTED
WageWorks, Inc.
WAGE
| – | – |
-8,385
| Closed | -$520K |
|
|
POT
186
DELISTED
Potash Corp Of Saskatchewan
POT
| – | – |
-31,360
| Closed | -$648K |
|
Similar funds
AMPWP
DCM
TLP
DCM
SSP
DIA
ACGDR
GEA
Radnor Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Radnor Capital Management held 188 positions worth $294M, down 5.9% from $313M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Radnor Capital Management's Q1 2018 filing shows 7 new, 10 increased, 89 reduced and 11 closed positions. Its largest new stake was Nutrien: 12,064 shares worth $570K. The largest sale was 3M, an estimated $1.74M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.
- Radnor Capital Management's largest Q1 2018 buy was Nutrien: 12,064 shares worth $570K.
- Radnor Capital Management added most to Meredith Corporation in Q1 2018, an estimated $320K increase.
- Radnor Capital Management's biggest Q1 2018 reduction was 3M, cutting an estimated $1.74M.
- Radnor Capital Management fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $648K.
- Radnor Capital Management's ten largest holdings make up 41% of its $294M portfolio in Q1 2018.
- Radnor Capital Management opened 7 new positions and closed 11 in Q1 2018.
- Radnor Capital Management's portfolio value fell 5.9% quarter-over-quarter to $294M.
Based on Radnor Capital Management's 13F filing for Q1 2018, filed 20 Apr 2018.